Reclast (Zoledronic Acid Injection) Manufactured by: Novartis |
|
|||||||||
| Name | Strength | Quantity | Price | ||||
| Brand | 5mg/100ml | 1 Vial Injection | $1299.99 | Buy |
All prices in USD
Reclast is a prescription medication that is injected once a year (or every two years; as per your treatment plan) for the treatment of osteoporosis in postmenopausal women. It is also approved for the treatment of Paget's disease of the bone. It belongs to a group of medications known as bisphosphonates.
Do not take Reclasta injections if you have already been treated by Zometa for the treatment of postmenopausal osteoporosis.
